Product Finder

Select by:

View all products
View all news

Other Products from this Line

Lirpan

Coated tablets x 5 and l0 mg: packages containing 30 coated tablets.


View more

Polper Vascular

Coated tablets: packages containing 10 and 30 bisected tablets.  Drinking ampoules: packages containing 30 drinking vials.


View more

Dercolina Infantil

15 g tube.


View more

Danlox

DANLOX 10: packages containing 28 capsules. DANLOX 20: packages containing 14 and 28 capsules. DANLOX 40: packages containing 14 and 28 capsules.


View more

Product Line:

Antiallergic Internal Medicine Geriatrics Otorhynolaringology Pediatrics Respiratory Neumo phthisiology Respiratory

Patient Product Information

Formulation:
MONTRATE 4: each chewing tablet contains: montelukast (as sodium salt) 4.00 mg; Excipients  c.s.; MONTRATE 5: each chewing tablet contains: montelukast (as sodium salt) 5.00 q.s; Excipients  q.s.; MONTRATE 10: each coated tablet contains: montelukast (as sodium salt) 10.00 mg

Therapeutic Action:
montelukast is a selective antagonist of the leukotriene receptors acting specifically on the cysteinyl leukotriene receptors and is active when orally administered.

Indications:
prophylaxis and treatment of chronic asthma in children older than 12 months and in adults. Treatment of asthmatic patients sensible to acetylsalicylic acid and prevention of bronchial spasm induced by exercise. Relief of seasonal allergic rhinitis symptoms in adults and children older than 2 years old.

Dosage and Administration Mode
- Children from 12 months to 2 years old with asthma: 4 mg once a day.
- Children from 2 to 5 years old with asthma and/or seasonal allergic rhinitis: one 4 mg chewable tablet a day, before going to bed.
- Children from 6 to 14 years old with asthma and/or seasonal allergic rhinitis: one 5 mg chewable tablet a day, before going to bed.
- Older than 15 years old and adults with asthma and/or seasonal allergic rhinitis: one 10 mg tablet a day, before going to bed.
The effects of montelukast on asthma are observed in the course of the first 24 hours. It may be taken with or without food; no dose adjustment is necessary in children, elderly, patients with renal insufficiency or mild to moderate hepatic failure, nor according to sex of patient. Montelukast may be associated to other antiasthmatic treatments and its dose may be reduced (bronchodilators or inhalation corticoids) if improvement of general symptoms is observed.

Contraindications:
hypersensitivity to any of the components of the product.

How Supplied:
Coated tablets: Packs containing 30 coated tablets. Chewing tablets: Packs containing 30 coated tablets.